O

OTLK

Outlook Therapeutics Inc

0.3061

-0.0090-2.86%
Opening10:55 04/27 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE0.3160/0.3151
TODAY RANGE0.3000-0.3190
VOL884.69K
MARKET CAP36.96M
52 WEEK RANGE0.1611-3.390
AVG VOL (3M)3.10M
% TURNOVER0.73%
TURNOVER--
P/E (TTM)-0.1129
% RANGE6.03%
EPS(TTM)-2.7115
P/E(FORWARD)-0.5278
P/B-0.5126
BVPS-0.5971
DIVIDEND--
P/S11.68
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP32.79M
SHARES OUTSTANDING120.74M
NEXT EARNINGS05/13-05/18
FREE FLOAT107.12M
LOT SIZE1
EX-DATE03/14/2024
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

OTLK

--

再生元製藥

REGN

-1.89%
751.57

GRDX

--

B

BIONTECH

BNTX

-0.09%
105.46

U

United Therapeutics Corp.

UTHR

-0.99%
567.16

V

Vertex Pharmaceuticals Inc

VRTX

-1.11%
430.29

S

Siga Technologie

SIGA

+0.88%
4.570

M

Moderna

MRNA

-4.01%
50.73

查爾斯河實驗室

CRL

+1.23%
169.80

M

Medpace控股

MEDP

+4.35%
410.54

T

Talphera Inc

TLPH

-3.00%
0.7750

I

ICON PLC

ICLR

-3.92%
102.17

泰邦生物

CBPO

0.00%
119.99

艾昆緯

IQV

+1.00%
162.28

MOLN

--

ARCT

--

吉利德科學

GILD

-2.42%
130.40

PRAH

--

因塞特醫療

INCY

-0.86%
94.65

A

Aptevo Therapeutics Inc

APVO

-0.31%
4.870

BSTC

--

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.